To Be Discontinued Tablet Cardiovascular
Bosentan Tablet · 459 days since initial FDA posting
Brand: TRACLEER
FDA lists Bosentan Tablet as To Be Discontinued (Actelion Pharmaceuticals).
No availability text on this FDA row.
Bosentan Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bosentan Tablet
- Manufacturer
- Actelion Pharmaceuticals
- Dosage Form
- Tablet
- Presentation
- Tracleer, Tablet, 125 mg (NDC 66215-102-03)
- Package NDC
- 66215-102-03
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jun 9, 2025
- Last Updated
- Jun 9, 2025
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.